missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

CNTF Polyclonal Antibody, Invitrogen™

CNTF Antibody, PA1-18365, from Invitrogen™. Species Reactivity: Human, Rat; Applications: ELISA, Immunohistochemistry, Western Blot.

Manufacturer:  Pierce Biotechnology Inc PA118365

Catalog No. 01-670-617


 

Specifications

Description

CNTF Antibody, PA1-18365, from Invitrogen. Species Reactivity: Human, Rat; Applications: ELISA, Immunohistochemistry, Western Blot.

CNTF is a survival promoting factor for different types of neurons in vitro and in vivo. The essential structural features for the biological function of human CNTF were investigated by Thier, M. et al. They showed that deletion of 14 N-terminal and 18 C-terminal amino acids significantly increased bioactivity compared to wild-type CNTF. CNTF is a survival factor for various neuronal cell types, which seems to prevent the degeneration of motor axons after axotomy.
Host Species: Sheep
Cross Reactivity: Human, Rat
Isotype: IgG
Immunogen: Recombinant human CNTF.
Formulation: 100μL unpurified antibody in whole serum and no preservative
Synonyms: Ciliary neurotrophic factor
Uniprot Accession: P20294, P26441
Entrez GeneID: 1270, 25707
Gene Symbol: CNTF
PA1-18365 detects CNTF from human, mouse, and rat samples. PA1-18365 has been successfully used in immunohistochemistry, Western blot, and ELISA procedures. The PA1-18365 immunogen is recombinant human CNTF. Reconstitute with 100 ul of distilled water.
Description & Specifications

Specifications

CNTF
Unlabeled
Serum
P20294, P26441
CNTF
Recombinant human CNTF.
100μL
Avoid Freeze/Thaw Cycles
Polyclonal
Human,Rat
ELISA,Immunohistochemistry,Western Blot
Human,Rat
100μL unpurified antibody in whole serum and no preservative
Ciliary neurotrophic factor
Sheep
IgG
Human, Rat
Primary
1270, 25707
Promotions

Promotions

  • Purchase any three Invitrogen™ Antibodies and receive a fourth antibody at no additional cost. This is an NLSU exclusive offer. You must apply and qualify for the program to be eligible.

    06/30/18